FDA Import Refusal AEK-0291404-1/10002/1 — NOVO NORDISK
The FDA refused shipment AEK-0291404-1/10002/1 from NOVO NORDISK (Canada) on Apr 13, 2026. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Apr 13, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 75